Serveur d'exploration sur l'esturgeon

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Stimulation of intracellular free calcium in GH3 cells by gamma3-melanocyte-stimulating hormone. Involvement of a novel melanocortin receptor?

Identifieur interne : 000030 ( Ncbi/Curation ); précédent : 000029; suivant : 000031

Stimulation of intracellular free calcium in GH3 cells by gamma3-melanocyte-stimulating hormone. Involvement of a novel melanocortin receptor?

Auteurs : L. Langouche [Belgique] ; M. Roudbaraki ; K. Pals ; C. Denef

Source :

RBID : pubmed:11145589

English descriptors

Abstract

The melanocortin (MC) gamma3MSH is a peptide that can be generated from the N-terminal domain of POMC and is believed to signal through the MC3 receptor. We recently showed that it induces a sustained rise in intracellular free calcium levels ([Ca(2+)](i)) in a subpopulation of pituitary cells, particularly in the lactosomatotroph lineage. In the present study we report that gamma3MSH and some analogs increase [Ca(2+)](i) in the GH- and PRL-secreting GH3 cell line and evaluate on the basis of pharmacological experiments and gene expression studies which MC receptor may be involved. A dose as low as 1 pM gamma3MSH induced an oscillating [Ca(2+)](i) increase in a significant percentage of GH3 cells. Increasing the dose recruited an increasing number of responding cells; a maximum was reached at 0.1 nM. gamma2MSH, alphaMSH, and NDP-alphaMSH displayed a similar effect. SHU9119, an MC3 and MC4 receptor antagonist, and an MC5 receptor agonist, did not affect the number of cells showing a [Ca(2+)](i) rise in response to gamma3MSH. SHU9119 had also no effect when added alone. MTII, a potent synthetic agonist of the MC3, MC4, and MC5 receptor as well as an N-terminally extended recombinant analog of gamma3MSH showed low potency in increasing [Ca(2+)](i) in GH3 cells, but high potency in stimulating cAMP accumulation in HEK 293 cells stably transfected with the MC3 receptor. In contrast, a peptide corresponding to the gamma2MSH sequence of POMC-A of Acipenser transmontanus increased [Ca(2+)](i) in GH3 cells, but was about 50 times less potent than gamma2- or gamma3MSH in stimulating cAMP accumulation in the MC3 receptor expressing HEK 293 cells. By means of RT-PCR performed on a RNA extract from GH3 cells, the messenger RNA of the MC2, MC3, and MC4 receptor was undetectable, but messenger RNA of the MC5 receptor was clearly present. These data suggest that the GH3 cell line does not mediate the effect of gamma3MSH through the MC3 receptor. The involvement of the MC5 receptor is unlikely, but cannot definitely be excluded. The findings animate the hypothesis that there exists a second, hitherto unidentified, MC receptor that displays high affinity for gamma3MSH.

DOI: 10.1210/endo.142.1.7878
PubMed: 11145589

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:11145589

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Stimulation of intracellular free calcium in GH3 cells by gamma3-melanocyte-stimulating hormone. Involvement of a novel melanocortin receptor?</title>
<author>
<name sortKey="Langouche, L" sort="Langouche, L" uniqKey="Langouche L" first="L" last="Langouche">L. Langouche</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Cell Pharmacology, University of Leuven, Medical School, Campus Gasthuisberg, B-3000 Leuven, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Cell Pharmacology, University of Leuven, Medical School, Campus Gasthuisberg, B-3000 Leuven</wicri:regionArea>
<wicri:noRegion>B-3000 Leuven</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Roudbaraki, M" sort="Roudbaraki, M" uniqKey="Roudbaraki M" first="M" last="Roudbaraki">M. Roudbaraki</name>
</author>
<author>
<name sortKey="Pals, K" sort="Pals, K" uniqKey="Pals K" first="K" last="Pals">K. Pals</name>
</author>
<author>
<name sortKey="Denef, C" sort="Denef, C" uniqKey="Denef C" first="C" last="Denef">C. Denef</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11145589</idno>
<idno type="pmid">11145589</idno>
<idno type="doi">10.1210/endo.142.1.7878</idno>
<idno type="wicri:Area/PubMed/Corpus">000631</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000631</idno>
<idno type="wicri:Area/PubMed/Curation">000631</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000631</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000631</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000631</idno>
<idno type="wicri:Area/Ncbi/Merge">000030</idno>
<idno type="wicri:Area/Ncbi/Curation">000030</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Stimulation of intracellular free calcium in GH3 cells by gamma3-melanocyte-stimulating hormone. Involvement of a novel melanocortin receptor?</title>
<author>
<name sortKey="Langouche, L" sort="Langouche, L" uniqKey="Langouche L" first="L" last="Langouche">L. Langouche</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Cell Pharmacology, University of Leuven, Medical School, Campus Gasthuisberg, B-3000 Leuven, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Cell Pharmacology, University of Leuven, Medical School, Campus Gasthuisberg, B-3000 Leuven</wicri:regionArea>
<wicri:noRegion>B-3000 Leuven</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Roudbaraki, M" sort="Roudbaraki, M" uniqKey="Roudbaraki M" first="M" last="Roudbaraki">M. Roudbaraki</name>
</author>
<author>
<name sortKey="Pals, K" sort="Pals, K" uniqKey="Pals K" first="K" last="Pals">K. Pals</name>
</author>
<author>
<name sortKey="Denef, C" sort="Denef, C" uniqKey="Denef C" first="C" last="Denef">C. Denef</name>
</author>
</analytic>
<series>
<title level="j">Endocrinology</title>
<idno type="ISSN">0013-7227</idno>
<imprint>
<date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adrenal Glands (metabolism)</term>
<term>Animals</term>
<term>Brain (metabolism)</term>
<term>CHO Cells</term>
<term>Calcium (metabolism)</term>
<term>Cell Line</term>
<term>Cricetinae</term>
<term>Cyclic AMP (metabolism)</term>
<term>Humans</term>
<term>Melanocyte-Stimulating Hormones (pharmacology)</term>
<term>Oligopeptides (pharmacology)</term>
<term>Pituitary Gland</term>
<term>Rats</term>
<term>Receptor, Melanocortin, Type 3</term>
<term>Receptor, Melanocortin, Type 4</term>
<term>Receptors, Corticotropin (drug effects)</term>
<term>Receptors, Corticotropin (genetics)</term>
<term>Receptors, Corticotropin (physiology)</term>
<term>Recombinant Proteins (pharmacology)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Thyrotropin-Releasing Hormone (pharmacology)</term>
<term>Transfection</term>
<term>alpha-MSH (analogs & derivatives)</term>
<term>gamma-MSH (pharmacology)</term>
<term>gamma-MSH (physiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>alpha-MSH</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en">
<term>Receptors, Corticotropin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Receptors, Corticotropin</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Calcium</term>
<term>Cyclic AMP</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Adrenal Glands</term>
<term>Brain</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Melanocyte-Stimulating Hormones</term>
<term>Oligopeptides</term>
<term>Recombinant Proteins</term>
<term>Thyrotropin-Releasing Hormone</term>
<term>gamma-MSH</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en">
<term>Receptors, Corticotropin</term>
<term>gamma-MSH</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>CHO Cells</term>
<term>Cell Line</term>
<term>Cricetinae</term>
<term>Humans</term>
<term>Pituitary Gland</term>
<term>Rats</term>
<term>Receptor, Melanocortin, Type 3</term>
<term>Receptor, Melanocortin, Type 4</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Transfection</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The melanocortin (MC) gamma3MSH is a peptide that can be generated from the N-terminal domain of POMC and is believed to signal through the MC3 receptor. We recently showed that it induces a sustained rise in intracellular free calcium levels ([Ca(2+)](i)) in a subpopulation of pituitary cells, particularly in the lactosomatotroph lineage. In the present study we report that gamma3MSH and some analogs increase [Ca(2+)](i) in the GH- and PRL-secreting GH3 cell line and evaluate on the basis of pharmacological experiments and gene expression studies which MC receptor may be involved. A dose as low as 1 pM gamma3MSH induced an oscillating [Ca(2+)](i) increase in a significant percentage of GH3 cells. Increasing the dose recruited an increasing number of responding cells; a maximum was reached at 0.1 nM. gamma2MSH, alphaMSH, and NDP-alphaMSH displayed a similar effect. SHU9119, an MC3 and MC4 receptor antagonist, and an MC5 receptor agonist, did not affect the number of cells showing a [Ca(2+)](i) rise in response to gamma3MSH. SHU9119 had also no effect when added alone. MTII, a potent synthetic agonist of the MC3, MC4, and MC5 receptor as well as an N-terminally extended recombinant analog of gamma3MSH showed low potency in increasing [Ca(2+)](i) in GH3 cells, but high potency in stimulating cAMP accumulation in HEK 293 cells stably transfected with the MC3 receptor. In contrast, a peptide corresponding to the gamma2MSH sequence of POMC-A of Acipenser transmontanus increased [Ca(2+)](i) in GH3 cells, but was about 50 times less potent than gamma2- or gamma3MSH in stimulating cAMP accumulation in the MC3 receptor expressing HEK 293 cells. By means of RT-PCR performed on a RNA extract from GH3 cells, the messenger RNA of the MC2, MC3, and MC4 receptor was undetectable, but messenger RNA of the MC5 receptor was clearly present. These data suggest that the GH3 cell line does not mediate the effect of gamma3MSH through the MC3 receptor. The involvement of the MC5 receptor is unlikely, but cannot definitely be excluded. The findings animate the hypothesis that there exists a second, hitherto unidentified, MC receptor that displays high affinity for gamma3MSH.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Eau/explor/EsturgeonV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000030 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000030 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Eau
   |area=    EsturgeonV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:11145589
   |texte=   Stimulation of intracellular free calcium in GH3 cells by gamma3-melanocyte-stimulating hormone. Involvement of a novel melanocortin receptor?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:11145589" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a EsturgeonV1 

Wicri

This area was generated with Dilib version V0.6.27.
Data generation: Sat Mar 25 15:37:54 2017. Site generation: Tue Feb 13 14:18:49 2024